Home » Supervisory activities on medical devices and in vitro diagnostic medical devices, 2021-2022 data

Supervisory activities on medical devices and in vitro diagnostic medical devices, 2021-2022 data

by admin
Supervisory activities on medical devices and in vitro diagnostic medical devices, 2021-2022 data

The Report on supervisory activities on medical devices 2021-2022 provides a description of the supervisory activities that the Ministry of Health, as the Competent Authority, carries out on medical devices and in vitro diagnostic medical devices.

The Report, the fourth on the subject of supervision of medical devices and the third on in vitro diagnostic medical devices, collects an analysis of the data present in the NSIS-Dispovigilance database relating to the years 2021-2022.

The publication is aimed at all stakeholders involved in the device sector, manufacturers, healthcare professionals, patient associations, local and central institutions interested in the purchase and management of medical devices and in vitro diagnostic medical devices.

Data on accidents and safety alerts, insights into certain sectors

The Report consists of an introductory part, in which a overview of the surveillance system on medical devices and in vitro diagnostic medical devices, of innovations introduced by the European Regulations on supervision and the structure and operational aspects of the supervisory system by analyzing both the European and national levels, with particular detail to national surveillance device network.

The Report on supervisory activities is divided into two sections:

the Description of accident data and safety alerts occurred in the years 2021-2022, with particular attention to some specific categories of devices

insights into some topics of particular interest emerged during the years 2021 and 2022.

The in-depth analyzes are specific to some sectors involving medical devices: devices in the orthopedic sector, administration, sampling and collection devices, devices in the cardiovascular and cardiovascular sector, devices in the gynecological sector, breast prostheses and healthcare and related components and accessories.

See also  EU, green light for five therapies against Covid by October 2021

A chapter is, in consideration of the pandemic context that continued to characterize the years 2021 and 2022, dedicated to the impact of the pandemic on the surveillance activity of medical devices and in vitro diagnostic medical devices.

There is also an in-depth analysis of the issue of the company supplying the device sterilization service (SterilMilano) and the problem of safety warnings regarding the degradation of the sound-absorbing foam of CPAP, PAP/BiPAP devices and mechanical ventilators of the manufacturer Respironics Inc.

The Report aims to disseminate the results of the analyzes deriving from the supervisory activity, in a transparent manner and with informative purposes.

Greater sensitization and awareness of all the actors involved in the surveillance system and transparent and shared information represent one of the priorities of the Ministry of Health, as a starting point for a active vigilance it’s at protection of public health.

For further information, consult:

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy